Results 71 to 80 of about 48,115 (292)

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes

Health and Quality of Life Outcomes, 2009
Background To explore the concept of the Minimum Clinically Important Difference (MID) of the Worry Scale of the Hypoglycaemia Fear Survey (HFS-II) and to quantify the clinical importance of different types of patient-reported hypoglycaemia.
Gonder-Frederick Linda, Stargardt Tom, Krobot Karl J, Alexander Charles M   +3 more
doaj   +1 more source

Hypoglycaemia gyermekkorban

, 2015
Szakdolgozatomban részletesen foglalkozom gyermekkori hypoglycaemia okaival és ellátásával.BSc/BAápolás és betegellátás ...
Kiss, Fruzsina
core  

Hypoglycaemia: Its pathophysiology in insulin treated diabetes and hypoglycaemia unawareness

, 2011
The limitations of current subcutaneous insulin delivery mean that hypoglycaemia is an inevitable side-effect of treatment of insulin-treated diabetes.
Simon R Heller
core   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Evaluating the association between diabetes, cognitive decline and dementia [PDF]

, 2015
The aim of this article is to review the association between diabetes mellitus, cognitive decline and dementia, including the effects of cognitive decline and dementia on self management of diabetes.
Brooke, Joanne, Omorogieva Ojo, Joanne Brooke, Ojo, Omorogieva   +3 more
core   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Body mass index is associated with hypoglycaemia in children with acute vomiting and dehydration.

PLoS ONE
BackgroundHealthy children from 7 months to 7 years are known to be at risk for developing hypoglycaemia during prolonged fasting, particularly during acute illness with decreased oral intake.
Simona Tarnokova, Lenka Langerova, Sabina Szoradova, Barbora Pitekova, Tomas Dallos, Juraj Stanik   +5 more
doaj   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk, Ryan Jin, Fabio Tuzzolino, Giusy Ranucci, Donatella Madonia, Alessio Provenzani   +5 more
wiley   +1 more source

Brain magnetic resonance imaging review suggests unrecognised hypoglycaemia in childhood

Frontiers in Endocrinology
IntroductionNeonatal and early-life hypoglycaemia, is a frequent finding but is often non-specific and asymptomatic, making detection and diagnosis challenging.
Chris Worth, Pon Ramya Gokul, Katie Ramsden, Sarah Worthington, Maria Salomon-Estebanez, Amit Maniyar, Indraneel Banerjee, Indraneel Banerjee   +7 more
doaj   +1 more source

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design

BMC Endocrine Disorders, 2012
Background Severe hypoglycaemia still represents a significant problem in insulin-treated diabetes. Most patients do not experience severe hypoglycaemia often.
Kristensen Peter, Pedersen-Bjergaard Ulrik, Beck-Nielsen Henning, Nørgaard Kirsten, Perrild Hans, Christiansen Jens, Jensen Tonny, Parving Hans-Henrik, Thorsteinsson Birger, Tarnow Lise   +9 more
doaj   +1 more source